Logos Global Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,000,000	Closed	-$4.53M	–	61
2024 Q3	$4.53M	Buy	5,000,000 +300,000	+6%	+$272K	0.49%	41
2024 Q2	$4.69M	Sell	4,700,000 -1,550,000	-25%	-$1.55M	0.38%	38
2024 Q1	$9.25M	Buy	+6,250,000	New	+$9.25M	0.75%	30